News & Updates

SAHPRA TV and Podcasts

Stay up to date with our latest news, media coverages, interviews and announcements on SAHPRA TV.

Safety alerts

PRODUCT RECALLS

Procter & Gamble South African Trading (Pty) Ltd, in consultation with the Medicines Control Council, wishes to alert the public that a small amount…

This recall is initiated as a result of product quality complaint logged with Aspen Pharmacare due to the discloration of Lethyl 30 mg tablets…

Following a customer complaint, we have identified the vitamin premix used in the manufacture of the affected product and batches contain additional vitamins and minerals…

Johnson & Johnson (Pty) Ltd, in consultation withe Medicine Control Council, is recalling the following batches of BENYLIN® products…

Publications

Cannabis and related substances information page.

A library of SAHPRA related guidelines.

The information on this page is for SAHPRA stakeholders, medical experts and members of the general public.

The annual report has been prepared in accordance with the guidelines on the annual report as issued by the National Treasury.

SOCIAL MEDIA FEEDS

1 day ago
SAHPRA Statement – Update on Sisonke Phase 3B Implementation Study -

Latest News:

SAHPRA has engaged with the Sisonke Phase 3B Implementation Study team and Janssen Pharmaceutica. The focus of the engagement was on the safety data reported from the Sisonke study, ... See more

SAHPRA, together with its scientific expert committees, has recently reviewed the data from the Sisonke Phase 3b implementation study.

4 days ago
SAHPRA Statement – Update on Sisonke Phase 3B Implementation Study -

Press release:

SAHPRA, together with its scientific expert committees, has recently reviewed the data from the Sisonke Phase 3b implementation study. This study involves the administration of the ... See more

SAHPRA, together with its scientific expert committees, has recently reviewed the data from the Sisonke Phase 3b implementation study.

5 days ago
National Department of Health (South Africa)

Minister of Health, Dr Zweli Mkhize today announced the temporary suspension of JnJ vaccine following FDA’s similar decision of Johnson and Johnson vaccine rollout in the United States #vaccine ... See more

6 days ago
Regulatory Compliance and overseeing Illicit medicines and products

Watch: Ms Daphney Fafudi, Regulatory Compliance manager at SAHPRA, discusses Regulatory Compliance and overseeing Illicit medicines and products.

Ms Daphney Fafudi, Regulatory Compliance manager at SAHPRA, discusses Regulatory Compliance and overseeing Illicit medicines and products.

6 days ago

SAHPRA will be partnering with Bio Africa in hosting a webinar that will focus on the South African landscape and regulatory processes of IKS, Medical Cannabis and Natural Products which will help ... See more

1 week ago
SAHPRA Statement- High Court Order - Ivermectin - SAHPRA

Press release:

On 6 April 2021 the Pretoria High Court issued a court order pertaining to four cases that were brought against SAHPRA and the Minister of Health regarding access to Ivermectin for ... See more

9 April 2021 On 6 April 2021 the Pretoria High Court issued a court order pertaining to four cases that were brought against SAHPRA and the Minister of Health regarding access to Ivermectin for use ... See more

1 week ago

The Government Communication and Information System in partnership with the Department of Science and Innovation, and the national Press Club will be hosting a webinar on the role of scientific ... See more

1 week ago
What SAHPRA does

Watch: The SAHPRA CEO discusses the mandate of SAHPRA

The SAHPRA CEO discusses the mandate of SAHPRA

1 week ago
Vaccines and their approval

Watch: SAHPRA CEO unpacks the process of vaccine approval

SAHPRA CEO unpacks the process of vaccine approval

2 weeks ago
SAHPRA registers Covid-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) with conditions

Latest News:

The South African Health Products Authority (SAHPRA) registered the Covid-19 Vaccine Janssen on 31 March 2021. The registration was done in terms of Section 15(6a) of the Medicines and ... See more

The South African Health Products Authority (SAHPRA) registered the Covid-19 Vaccine Janssen on 31 March 2021.

« 1 of 4 »

Join our webinar: Navigating South Africa’s Cannabis Future as we focus on the South African landscape and regulatory processes which will help navigate South Africa’s Cannabis Future and unlock our potential.

Click the link below to register:

https://lnkd.in/d_m2Sj9
#Cannabis

Load More...